For Admin
A Leading Company in Nasal Drug Delivery
SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.
3D Nasal Cast Model
May 19, 2023
Satsuma Pharmaceuticals Announces FDA Acceptance of NDA for STS101, a Novel and Investigational DHE Nasal Powder Product for the Acute Treatment of Migraine
April 17, 2023
SNBL Enters into Definitive Agreement to Acquire Satsuma Pharmaceuticals, Inc.
2023|2022|2021|2020|2019|2018|2016|2015|2014|2013|2012〜